Back to calendar
First Tracks Biotherapeutics, Inc. (TRAX) Earnings
TRAX reports earnings on Tuesday, November 3, 2026
earnings report
November 3, 2026 · After Market Close
Q3 2026
Est. EPS: $-0.79
Actual EPS: $-0.88
EPS surprise: 2.52%
Company overview
Market Cap$2.1B
PriceUSD 49.04
52-week high50.17
52-week low14.72
SectorHealth Technology
IndustryBiotechnology